Die Therapie gegen Lungenkrankheit von FibroGen scheitert im späten Stadium.

Published Date: 01 Jul 2023

FibroGen reported on Monday that a late-stage study using an experimental drug for a chronic lung disease had not been able to significantly slow the decline in a crucial lung function indicator.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Common intracellular toxin could help fight leukemia

2.

CAR T-Cell Therapy Shows Promise in Mantle Cell Lymphoma

3.

Scholastic performance is a key concern for young cancer patients, study finds

4.

AACR: American Association for Cancer Research

5.

Lung Cancer Screening Rates in Eligible Adults Remain Low, Uneven


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot